Author Archives: Trista Morrison

To BioWorld: Farewell! All My Best. With Love, Trista

As many of you know, after six wonderful years with BioWorld, I’m moving on to take a position as associate director of corporate communications with Ironwood Pharmaceuticals. When BioWorld asked me to write a farewell blog post, I jumped at…

Share

Biotech Fundraising Dips in Q112, But No Need to Panic

I’m seeing lots of references to BioWorld’s recent analysis by Cynthia Robbins-Roth showing that U.S.-based, VC-backed biotechs raised $391 million in the first quarter, a 34 percent increase compared to the same period last year. That’s good news, especially given…

Share

Defining Specialty Pharma: What is it, Can it Innovate, and Does it Matter?

The article I wrote last week for FierceBiotech on the relationship between Series A funding and innovation led to an interesting discussion with Bruce Booth, partner at Atlas Venture and biotech blogger extraordinaire. The crux of my article was this:…

Share

2010-12 Biotech IPOs Not Performing THAT Bad. Really.

What a difference two weeks makes. When I was researching last week’s BioWorld Insight cover – about how emerging biotech Verastem Inc., mature biotech Ironwood Pharmaceuticals Inc. and specialty pharma firm Clovis Oncology Inc. shared some surprising similarities in how…

Share

Licensing or Acquisition? Big Pharma Shares How They (and YOU) Decide

When I was at the Biocom Global Life Science Partnering Conference last week, one of the more interesting debates I heard was about whether it’s better to in-license an asset or acquire the whole company. While every case is different…

Share

Like Warren Buffett, J&J Throws Down Incubator Gauntlet . . .Who’s Next?

When people talk about Johnson and Johnson’s new San Diego incubator, Janssen Labs, they can’t help but be a little bit skeptical about the fact that J&J isn’t taking any options or first-rights to compounds developed by its incubator tenants….

Share

San Diego Scene: Sanford-Burnham Queuing Up Behind J&J to Launch Incubator

The San Diego biotech industry has been buzzing this week with the grand opening of Johnson and Johnson’s new incubator, Janssen Labs. But already plans for another San Diego incubator are being laid, this time at the Sanford-Burnham Medical Research…

Share

Five New Trends in Biotech Venture

The cover story for BioWorld Insight this week is about the biotech venture capital world, and how despite its much-publicized contraction, there’s a lot of exciting stuff going on like established firms closing new funds, established players regrouping to form…

Share

He Said What?!?! Best Biotech Quotes of 2011

As BioWorld Insight readers know, our “Word on the Street” column provides a sample of the most entertaining and thought-provoking quotes our staff stumbles upon each week. Some are gathered during interviews, some gleaned from analyst reports, and some overheard…

Share

BioWorld’s Fifth Annual Biotech Holiday Gift Guide

While all you biotechs out there scramble to meet your end-of-year milestones, BioWorld would like to announce a little milestone of our own. That’s right, this is our fifth annual biotech holiday gift guide. To celebrate five years of excellent…

Share